Skip to content
AwardedPRTGoods€1,553,250

aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV

Published
Published 17 April 2025

Overview

aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€1,553,250
Procedure
Direct
Published
17 April 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1,481,490
Award date
26 March 2025
Contract period
— → 21 March 2026
Winner
  • Imprensa Nacional-Casa da Moeda, S. A. (INCM)

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 April 2025

Contracting authority

  • Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.

    Procuring entity

    porto, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV — won by Imprensa Nacional-Casa da Moeda, S. A. (INCM) — Skim